Klotho Neurosciences, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
Klotho Neurosciences, Inc. filed an S-1 registration statement for the resale of up to 35 million shares of common stock by existing selling stockholders, including shares convertible from Series C Preferred Stock.
Klotho Neurosciences is registering for resale up to 43.7 million shares of common stock, including shares issuable upon conversion of notes and exercise of warrants, by existing shareholders.
ANEW Medical, Inc. files an amendment to its S-1 registration statement primarily to include a revised exhibit related to auditor consent.
ANEW Medical is registering for resale up to 21.5 million shares of its common stock, including shares issuable upon warrant exercises and shares held by selling stockholders.